| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-30 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-25 |
|---|---|---|---|
| Revenue (Total Sales) | $452.0M | $551.3M | $632.8M |
| YoY Revenue Growth % | -18.0% | -12.9% | — |
| Gross Profit | $169.7M | $207.4M | — |
| Gross Margin % | 37.5% | 37.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$38.3M | -$196.8M | $28.8M |
| Operating Margin % | -8.5% | -35.7% | 4.5% |
| Net Income (GAAP) | -$40.6M | -$191.8M | $21.0M |
| EBITDA (Normalized) | -$37.6M | -$194.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.4M | $18.9M | $21.9M |
| Capital Expenditures (CapEx) | $808.0K | $2.7M | — |
| Free Cash Flow (FCF) | $619.0K | $16.2M | $21.9M |
| FCF Margin % | 0.1% | 2.9% | 3.5% |
| Return on Invested Capital (ROIC %) | -28.9% | -45.0% | — |
| Cash & Short-Term Equivalents | $89.8M | $78.2M | — |
| Total Debt (Short + Long Term) | — | $0 | — |
| Total Stockholders' Equity | $194.6M | $325.7M | — |